An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Bermel, MD,MBA
Director Mellen Center for Multiple Sclerosis, Cleveland Clinic
Principal Investigator - Robert Shin, MD,FANA
Prof of Neurology MedStar Georgetown University Hospital
Principal Investigator - Shiv Saidha, MD,MRCPI
Prof of Neurology, Johns Hopkins Hospital, Baltimore MD
Principal Investigator - Sylvia Klineova, MD,MS
Assistant Prof of Neurology Icahn School of Medicine at Mt Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Johns Hopkins University
Baltimore, Maryland, United States
- Medstar Health
Chevy Chase, Maryland, United States
- Corinne Goldsmith Dickinson Center for Ms
New York, New York, United States
- Mellen Center
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Mar 2023
- Primary completion
- 30 Apr 2024
- Completion
- 30 Apr 2024
- Last update posted
- 11 Jun 2024
- Registered enrollment
- 137
- Registry id
- NCT05663853
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.